AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Quanterix (NASDAQ:QTRX) and Sotera Health (NASDAQ:SHC).
AbCellera Biologics has a consensus price target of $21.00.
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.9787 last updated February 24, 2025 at 5:45 PM EST.
There are no upcoming dividends for AbCellera Biologics.
AbCellera Biologics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for AbCellera Biologics.
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.